Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01707550
NCT01707550
Completed
Not Applicable

Observational, Non-interventional Survey of Renal Allograft Recipients Receiving CellCept as Part of Their Immunosuppressive Protocol

Hoffmann-La Roche0 sites414 target enrollmentStarted: December 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsKidney Transplantation

Overview

Phase
Not Applicable
Status
Completed
Enrollment
414
Primary Endpoint
Average dose of CellCept used in immunosuppressive protocols in Serbia
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

This observational survey study will capture all renal transplant patients in Serbia who are currently receiving CellCept (mycophenolate mofetil) as part of their immunosuppressive protocol.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients, \>/= 18 years of age
  • •Recipients of renal allograft
  • •Patients receiving CellCept

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Average dose of CellCept used in immunosuppressive protocols in Serbia

Time Frame: 9 months

Average dose of concomitant immunosuppressive drugs

Time Frame: 9 months

Secondary Outcomes

  • Average duration of post-transplant period for patients in Serbia receiving CellCept(9 months)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Completed
Not Applicable
Associating Renal Transplantation With the ITN Signature of ToleranceKidney Transplantation
NCT01516177National Institute of Allergy and Infectious Diseases (NIAID)250
Completed
Not Applicable
Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft RejectionChronic Kidney Insufficiency
NCT01353417Sandoz102
Unknown
Not Applicable
TransplantLines: the Transplantation BiobankSolid Organ Tranplant Recipients, 18+ Years
NCT03272841University Medical Center Groningen3,000
Withdrawn
Not Applicable
Observational Registry Study of Renal Transplant PatientsKidney Transplant
NCT01284257Novartis Pharmaceuticals
Active, not recruiting
Not Applicable
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure RegistryKidney Transplant Rejection
NCT03326076CareDx4,000